Vanguard Group Inc Codex Dna, Inc. Transaction History

Vanguard Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	N/A	-8,909 Reduced 2.09%	418,293 $773,000
Q1 2023 May 15, 2023	BUY	$1.3 - $2.15 $22,019 - $36,416	16,938 Added 4.13%	427,202 $790,000
Q4 2022 Feb 10, 2023	BUY	$1.12 - $1.69 $183 - $277	164 Added 0.04%	410,264 $492,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.36 $154,256 - $214,144	90,739 Added 28.41%	410,100 $681,000
Q2 2022 Aug 12, 2022	SELL	$1.8 - $6.45 $76,554 - $274,318	-42,530 Reduced 11.75%	319,361 $575,000
Q1 2022 May 13, 2022	BUY	$4.12 - $10.36 $193,532 - $486,650	46,974 Added 14.92%	361,891 $1.94 Million
Q4 2021 Feb 14, 2022	SELL	$6.31 - $11.96 $716,235 - $1.36 Million	-113,508 Reduced 26.49%	314,917 $3.4 Million
Q3 2021 Nov 12, 2021	BUY	$10.15 - $19.88 $3.84 Million - $7.52 Million	378,425 Added 756.85%	428,425 $4.77 Million
Q2 2021 Aug 13, 2021	BUY	$17.76 - $22.0 $888,000 - $1.1 Million	50,000 New	50,000 $1.1 Million

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.